DEAL: Redx Pharma’s corporate rescue – International Financial Law Review
Redx Pharmas transition from administration back to trading on AIM is an unprecedented move for a UK company. The UK-based drug R&D company was declared insolvent in May after missing a repayment deadline for a £2 million ($2.62 million) secured loan from Liverpool City Council dating from 2012. It was…